  There are many other issues that concern philosophers in the domain of global health. There are increasingly worrying practices of experimentation on disadvantaged subjects in developing countries. Increasingly, clinical research has been outsourced to poor, developing countries with populations that are often highly vulnerable. We might wonder about whether these populations are being exploited and whether the participants have compromised abilities to consent to drug trials. In many cases the trials bring considerable health benefits that would not come their way were it not in the interests of pharmaceutical companies to do clinical research in those locations. If sufficient benefits accrue for local populations some argue that these cases need not be of concern (London 2011).